Variant report
Variant | nsv610002 |
---|---|
Chromosome Location | chr8:6211581-6214753 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17599287 | chr8:6211581-6211582 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs112135335 | chr8:6211592-6211593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs185535274 | chr8:6211596-6211597 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs571278775 | chr8:6211602-6211603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs374966795 | chr8:6211612-6211613 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs2920642 | chr8:6211619-6211620 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs550699638 | chr8:6211649-6211650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs567889277 | chr8:6211657-6211658 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs547592033 | chr8:6211665-6211666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs2920641 | chr8:6211679-6211680 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs572922882 | chr8:6211748-6211749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs538938123 | chr8:6211784-6211785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs190642227 | chr8:6211789-6211790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs139445061 | chr8:6211796-6211797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs375623806 | chr8:6211830-6211831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs538521403 | chr8:6211850-6211851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs561088336 | chr8:6211851-6211852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs2166007 | chr8:6211852-6211853 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs2916704 | chr8:6211859-6211860 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs560761314 | chr8:6211869-6211870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs1550695 | chr8:6211871-6211872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs17599378 | chr8:6211879-6211880 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs74800147 | chr8:6211900-6211901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs17599420 | chr8:6211908-6211909 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs1550694 | chr8:6211985-6211986 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs372961463 | chr8:6212009-6212010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs550578518 | chr8:6212011-6212012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs567276742 | chr8:6212031-6212032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs2916703 | chr8:6212050-6212051 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs144084828 | chr8:6212067-6212068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs566666244 | chr8:6212095-6212096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs542727029 | chr8:6212146-6212147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs181741864 | chr8:6212165-6212166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs186918784 | chr8:6212192-6212193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs192071375 | chr8:6212201-6212202 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs183971266 | chr8:6212203-6212204 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs556263805 | chr8:6212260-6212261 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs146500135 | chr8:6212280-6212281 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs186036001 | chr8:6212305-6212306 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs12056733 | chr8:6212422-6212423 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs577372869 | chr8:6212430-6212431 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs546417348 | chr8:6212446-6212447 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs35513920 | chr8:6212449-6212450 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs190894342 | chr8:6212471-6212472 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs532019536 | chr8:6212473-6212474 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs149056553 | chr8:6212482-6212483 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs560953501 | chr8:6212483-6212484 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs115420075 | chr8:6212486-6212487 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs143081171 | chr8:6212491-6212492 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs566439772 | chr8:6212513-6212514 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Cancer | 20164920 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Gastric cancer | 18160780 | CNVD |
Breast cancer | 21990379 | CNVD |
Psoriasis | 20403174 | CNVD |
Psoriasis | 20663923 | CNVD |
Crohn''s disease | 16909382 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Crohn''s disease | 20877625 | CNVD |
Inflammatory disorder | 20877625 | CNVD |
Cardiac defect | 21933911 | CNVD |
Psoriasis | 18059266 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Psoriasis | 20877625 | CNVD |
Mental retardation | 17847001 | CNVD |
Prostate cancer | 17217626 | CNVD |
Schizophrenia | 21399695 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Psoriasis | 18848619 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Colorectal cancer | 17229543 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:6200000-6216600 | Weak transcription | Pancreas | Pancrea |
2 | chr8:6209200-6212200 | Weak transcription | Fetal Stomach | stomach |
3 | chr8:6212200-6212400 | Enhancers | Small Intestine | intestine |
4 | chr8:6212200-6212600 | Enhancers | Fetal Brain Female | brain |
5 | chr8:6212200-6213400 | Enhancers | Fetal Stomach | stomach |
6 | chr8:6212200-6213600 | Enhancers | Fetal Muscle Leg | muscle |
7 | chr8:6212400-6212800 | Enhancers | H1 Cell Line | embryonic stem cell |
8 | chr8:6212400-6212800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
9 | chr8:6212400-6212800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr8:6212400-6212800 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
11 | chr8:6212400-6212800 | Enhancers | Fetal Muscle Trunk | muscle |
12 | chr8:6212600-6212800 | Enhancers | Gastric | stomach |
13 | chr8:6212800-6216600 | Weak transcription | Gastric | stomach |
14 | chr8:6212800-6218400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |